Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 5Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Lymphoma 2Glioblastoma 2Vulvar Neoplasms 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Acute 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Gliosarcoma 1Glioma 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

tremelimumab 2fludarabine 2durvalumab 2aflibercept 2Trastuzumab 2Radiotherapy 2Radiosurgery 2Cyclophosphamide 2Cisplatin 2tipifarnib 1sapropterin 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1Vaccines 1Topotecan 1Therapeutics 1Radiation 1Platinum 1Pharmacogenomic Testing 1Papillomavirus Vaccines 1Nelfinavir 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunoglobulin G 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gemcitabine 1Ganciclovir 1E6 protein, Human papillomavirus type 16 1Docetaxel 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Vulvar Neoplasms × Nelfinavir × Clear all
NCT04169763 2026-05-20

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

M.D. Anderson Cancer Center

Phase 1 Recruiting
25 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡